EssilorLuxottica (OTCMKTS:ESLOY) Stock Rating Upgraded by Hsbc Global Res

EssilorLuxottica (OTCMKTS:ESLOY) was upgraded by equities research analysts at Hsbc Global Res to a “strong-buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Several other analysts have also issued reports on the stock. Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday. Royal Bank Of Canada restated an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, October 28th. Finally, Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy”.

EssilorLuxottica Price Performance

Shares of EssilorLuxottica stock opened at $162.99 on Wednesday. EssilorLuxottica has a one year low of $123.09 and a one year high of $186.81. The business has a 50-day simple moving average of $169.59 and a 200 day simple moving average of $161.64. The company has a quick ratio of 0.67, a current ratio of 0.97 and a debt-to-equity ratio of 0.18.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.